| review article | Q7318358 |
| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | Abdel-Rahman El-Zayadi | |
| P2860 | cites work | Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes | Q22008015 |
| HNE interacts directly with JNK isoforms in human hepatic stellate cells | Q24564300 | ||
| Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C | Q27477981 | ||
| STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER? | Q27478329 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| The adipocyte-secreted protein Acrp30 enhances hepatic insulin action | Q28505765 | ||
| Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport | Q28570514 | ||
| Increased oxidative stress in obesity and its impact on metabolic syndrome | Q29012150 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 | ||
| Molecular mediators of hepatic steatosis and liver injury | Q29616709 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Mitochondrial dysfunction in the elderly: possible role in insulin resistance | Q29618783 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein | Q29620682 | ||
| High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C. | Q33788303 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association | Q34112671 | ||
| Oxidative stress-related molecules and liver fibrosis | Q34387346 | ||
| Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease | Q34427653 | ||
| Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma | Q34544988 | ||
| The GLUT4 glucose transporter | Q34614833 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. | Q35206324 | ||
| A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. | Q35285121 | ||
| Host factors and failure of interferon-alpha treatment in hepatitis C virus | Q35730979 | ||
| Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease | Q35872177 | ||
| Recent concepts in non-alcoholic fatty liver disease | Q36234172 | ||
| Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications | Q36286313 | ||
| Insulin resistance: a metabolic pathway to chronic liver disease | Q36297331 | ||
| Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease | Q36304141 | ||
| Review article: Drug therapy for non-alcoholic fatty liver disease | Q36360551 | ||
| Therapy of hepatitis C: from empiricism to eradication | Q36382235 | ||
| Pathophysiology of nonalcoholic steatohepatitis | Q36422705 | ||
| Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment | Q37051418 | ||
| The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms | Q40140184 | ||
| Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. | Q40474758 | ||
| Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid | Q40818220 | ||
| Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance | Q42457824 | ||
| Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells | Q42503776 | ||
| Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a | Q42687643 | ||
| Insulin resistance and hepatitis C. | Q42726120 | ||
| Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes | Q42826146 | ||
| Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype | Q42981551 | ||
| Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. | Q42988688 | ||
| Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. | Q42999424 | ||
| Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity | Q43031928 | ||
| Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors | Q43035123 | ||
| Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels | Q43036603 | ||
| Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients | Q43040025 | ||
| Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. | Q43047842 | ||
| Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. | Q43588122 | ||
| Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. | Q43755028 | ||
| NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome | Q43875846 | ||
| Fibrogenic impact of high serum glucose in chronic hepatitis C. | Q44182966 | ||
| Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis | Q44324967 | ||
| Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. | Q44643929 | ||
| Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes | Q44675026 | ||
| Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome | Q44897636 | ||
| The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years | Q45787554 | ||
| Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats | Q46650962 | ||
| Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. | Q46967704 | ||
| The natural history of nonalcoholic fatty liver disease: a clinical histopathological study | Q47617617 | ||
| Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. | Q47732731 | ||
| Association of nonalcoholic fatty liver disease with insulin resistance. | Q51559831 | ||
| Obesity and its nurturing effect on hepatitis C. | Q53919637 | ||
| Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis | Q58622840 | ||
| Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis | Q74027130 | ||
| Nonalcoholic fatty liver disease | Q74119103 | ||
| The 1st World Congress on the Insulin Resistance Syndrome | Q75346145 | ||
| Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies | Q80594561 | ||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| P304 | page(s) | 4120-6 | |
| P577 | publication date | 2008-07-14 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Hepatic steatosis: a benign disease or a silent killer | |
| P478 | volume | 14 |
| Q92164007 | A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years |
| Q28081433 | Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use |
| Q43039505 | Chronic hepatitis C infection and insulin resistance: two best friends |
| Q42751607 | Clinical characteristics associated with hepatic steatosis on ultrasonography in patients with elevated alanine aminotransferase |
| Q37143317 | Elevated Linoleic Acid (A Pro-Inflammatory PUFA) and Liver Injury in a Treatment Naive HIV-HCV Co-Infected Alcohol Dependent Patient |
| Q34467266 | Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies |
| Q37349796 | Endocrine manifestations of hepatitis C virus infection. |
| Q92885202 | Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease |
| Q38766181 | Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells |
| Q61910384 | Infections virales et diabète en Afrique |
| Q42992657 | Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype |
| Q42054982 | Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells |
| Q51557991 | Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease. |
| Q64052598 | Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study |
| Q55315481 | Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions. |
| Q64997917 | Rational arrangement of measuring shear wave speed in the liver. |
| Q39979280 | Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study |
| Q26798101 | Steatosis and hepatitis C |
| Q42131040 | Steatosis-induced proteins adducts with lipid peroxidation products and nuclear electrophilic stress in hepatocytes |
| Q97885508 | Systemic Nanoparticle-Mediated Delivery of Pantetheinase Vanin-1 Regulates Lipolysis and Adiposity in Abdominal White Adipose Tissue |
| Q42152130 | The impact of host metabolic factors on treatment outcome in chronic hepatitis C. |
Search more.